TABLE 9.

Signals of ADRs.

Drug	ADR	ROR	95% CI lower limit	PRR	95% CI lower limit	χ2
Pembrolizumab	Pneumonitis	39.93	8.28	28.25	8.77	104632.48
Rituximab	Urticaria	10.49	1.08	10.27	1.09	16193.88
Sintilimab	Hepatic failure a	6.96	1.61	6.59	1.62	9109.80
Sintilimab	Hyperthyroidism	9.49	2.46	8.78	2.48	6804.49
Camrelizumab	Hyperthyroidism	7.74	2.02	7.27	2.03	5081.48
Camrelizumab	Pneumonitis	4.74	1.15	4.54	1.16	5049.10
Camrelizumab	Hypothyroidism	9.87	2.76	9.09	2.79	3780.48
Bevacizumab	Hypertension	12.35	3.53	11.32	3.55	1691.69
Nimotuzumab	Fever	5.91	1.29	3.80	1.50	457.11
Bevacizumab	Vomiting	3.28	1.36	3.04	1.38	197.76
Trastuzumab	Vomiting	2.27	1.01	2.18	1.03	73.28
Sintilimab	Rash	2.63	1.23	2.29	1.26	42.36
Rituximab	Dyspnea	5.15	2.30	4.67	2.33	22.22
Trastuzumab	Chills	3.74	2.17	3.18	2.22	5.98

^aOff-label ADR.